Liu X D, Deng N, Huang S K
Department of Pharmacology, China Pharmaceutical University, Nanjing.
Yao Xue Xue Bao. 1991;26(10):725-32.
Disposition kinetics of procainamide (PA) and its metabolite N-acetylprocainamide (NAPA) in rats was simulataneously predicted by a physiological pharmacokinetic model. The parameters, such as clearances in kidney and liver and tissue/blood concentration ratios, which were needed for simulations, were determined. The estimated clearances of PA in rat blood, kidney and liver were 47. 28, 13. 56 and and 33. 71 ml.kg-1.min-1, respectively. Tissue/blood drug concentration ratios were obtained after iv administration according to Gallo's method and demonstrated that heart, liver, kidney, muscle and small intestine have greater affinity for PA than do blood components. The concentrations of PA and NAPA in rat tissues following iv administration of PA.HCl 75 mg/kg were predicted and compared with observed values. The results showed that a good agreement between predictions and observed data was found in most of rat tissues. Concentrations of PA and NAPA in plasma of man, based on scaling-up of kinetics of PA and NAPA from rat to man, was also simulated.
通过生理药代动力学模型同时预测了普鲁卡因胺(PA)及其代谢产物N - 乙酰普鲁卡因胺(NAPA)在大鼠体内的处置动力学。确定了模拟所需的参数,如肾脏和肝脏中的清除率以及组织/血液浓度比。大鼠血液、肾脏和肝脏中PA的估计清除率分别为47.28、13.56和33.71 ml·kg-1·min-1。静脉给药后,根据加洛方法获得组织/血液药物浓度比,结果表明心脏、肝脏、肾脏、肌肉和小肠对PA的亲和力高于血液成分。预测了静脉注射75 mg/kg PA.HCl后大鼠组织中PA和NAPA的浓度,并与观察值进行比较。结果表明,在大多数大鼠组织中,预测值与观察数据之间具有良好的一致性。基于从大鼠到人的PA和NAPA动力学放大,还模拟了人体血浆中PA和NAPA的浓度。